Medpace Holdings, Inc. (MEDP) vs Meta Platforms, Inc. (META)
A side-by-side comparison of Medpace Holdings, Inc. and Meta Platforms, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.
Different business models: MEDP is classified in Healthcare; META is classified in Communication Services. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
MEDP
Medpace Holdings, Inc.
$587.52HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
META
Meta Platforms, Inc.
$648.03Communication ServicesDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — MEDP vs META
growth of $100 · dividends reinvested · last 10yMEDP +1860.2% (+34.7%/yr)META +411.4% (+17.7%/yr)MEDP compounded faster over this window
MEDP META
MEDP vs META: by the numbers
- •META is the larger company ($1.65T vs $16.40B market cap).
- •META trades at the lower trailing earnings multiple (24.42 vs 34.42 P/E), one valuation lens rather than an overall verdict.
- •META converts more revenue to profit (29.84% vs 17.67% net margin).
- •MEDP grew revenue faster over the past five years (22.03% vs 16.85% CAGR).
- •META pays a dividend (0.33% yield), while MEDP has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | MEDP | META |
|---|---|---|
| P/E ratio | 34.42 | 24.42 |
| Forward P/E | 33.38 | 20.64 |
| P/S ratio | 5.89 | 7.23 |
| P/B ratio | 37.80 | 6.32 |
| EV / EBITDA | 26.20 | 15.94 |
| FCF yield | 4.28% | 2.48% |
Profitability
| Metric | MEDP | META |
|---|---|---|
| Gross margin | 28.76% | 81.75% |
| Operating margin | 20.97% | 38.08% |
| Net margin | 17.67% | 29.84% |
| ROE | 113.29% | 26.07% |
| ROIC | 77.00% | 17.18% |
Dividends
| Metric | MEDP | META |
|---|---|---|
| Dividend yield | N/A | 0.33% |
| Payout ratio | N/A | 7.91% |
Growth (annualized)
| Metric | MEDP | META |
|---|---|---|
| Revenue CAGR (5Y) | 22.03% | 16.85% |
| EPS CAGR (5Y) | 30.90% | 18.60% |
| FCF CAGR (5Y) | 23.40% | 4.96% |
| Total return CAGR (5Y) | 24.92% | 11.41% |
Frequently asked
- Which has the lower trailing P/E, MEDP or META?
- META has the lower trailing P/E: MEDP trades at 34.42 and META at 24.42. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, MEDP or META?
- Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus META at 16.85%.
- Does MEDP or META pay a bigger dividend?
- META pays a dividend (0.33% yield), while MEDP has no payments in the available dividend history.
- Is MEDP or META more profitable?
- META runs the higher net margin — MEDP at 17.67% versus META at 29.84%.
- How have MEDP and META total returns compared?
- Over the past 10 years, MEDP delivered 34.74% and META delivered 17.72% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Medpace P/E ratioMeta Platforms P/E ratioMeta Platforms dividend yieldMedpace ROEMeta Platforms ROEMedpace operating marginMeta Platforms operating marginMedpace revenue growthMeta Platforms revenue growthMedpace free cash flowMeta Platforms free cash flow
Medpace & Meta Platforms appear in these rankings
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.